S1-induced vasospastic angina—diagnostic utility of Holter ECG: a report of a case
Abstract Background Vasospastic angina is a rare but potentially life-threatening adverse event (AE) of S1, an oral fluoropyrimidine anticancer agent. However, this AE is not well known owing to its low incidence. We report herein a case of a patient who suffered from vasospastic angina associated w...
Main Authors: | Tatsuo Kanda, Atsuhiro Wakai, Tadasu Chida, Yuichi Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-08-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40792-020-00975-x |
Similar Items
-
Diagnostic Utility and Pathogenic Role of Circulating MicroRNAs in Vasospastic Angina
by: Chan Soon Park, et al.
Published: (2020-05-01) -
Hyperthyroidism Is Associated with the Development of Vasospastic Angina, but Not with Cardiovascular Outcomes
by: Hyun-Jin Kim, et al.
Published: (2020-09-01) -
A case of vasospastic angina. Vasospasm physiopathology: a new therapeutic role for ranolazine?
by: Carlo Uran, et al.
Published: (2020-08-01) -
Vasospastic angina: pathophysiology and clinical significance
by: B. I. Geltser, et al.
Published: (2020-03-01) -
Intracoronary Thrombogenicity in Patients with Vasospastic Angina: An Observation Using Coronary Angioscopy
by: Hiroki Teragawa, et al.
Published: (2021-09-01)